| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 10/20/2011 | US20110256183 Hydrogels with network defects enhanced by nanoparticle incorporation |
| 10/20/2011 | US20110256180 Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof |
| 10/20/2011 | US20110256175 Amino lipids and methods for the delivery of nucleic acids |
| 10/20/2011 | US20110256168 Conjugates that Contain the Homeodomain of Antennapedia |
| 10/20/2011 | US20110256160 Adherent cells from placenta tissue and use thereof in therapy |
| 10/20/2011 | US20110256159 Adherent cells from placenta tissue and use thereof in therapy |
| 10/20/2011 | US20110256154 Anti-erbb3 antibodies |
| 10/20/2011 | US20110256153 CD37-Binding Molecules and Immunoconjugates Thereof |
| 10/20/2011 | US20110256152 Methods Of Treating And Preventing Glucose Toxicity |
| 10/20/2011 | US20110256151 Antibodies to human il-1beta |
| 10/20/2011 | US20110256150 Modulation of Axon Degeneration |
| 10/20/2011 | US20110256145 Connective Tissue Growth Factor-3 (CTGF-3) |
| 10/20/2011 | US20110256138 Amyloid-beta binding proteins |
| 10/20/2011 | US20110256137 Pharmaceutical composition comprising a bispecific antibody for epcam |
| 10/20/2011 | US20110256133 Anti-polyubiquitin antibodies and methods of use |
| 10/20/2011 | US20110256132 Myostatin binding proteins |
| 10/20/2011 | US20110256127 Anti-lrp6 antibodies |
| 10/20/2011 | US20110256120 Methods and Compositions for Reducing Amyloid Beta Levels |
| 10/20/2011 | US20110256117 Manufacturing and use of composite scaffolds |
| 10/20/2011 | US20110256114 T-cell receptor and nucleic acid encoding the receptor |
| 10/20/2011 | US20110256113 Method for preventing and treating diabetes using neurturin |
| 10/20/2011 | US20110256112 Compensating for Atrioventricular Block Using a Nucleic Acid Encoding a Sodium Channel or Gap Junction Protein |
| 10/20/2011 | US20110256111 Isolated multipotent mesenchymal stem cell from human adult glomeruli (hgl-msc), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney |
| 10/20/2011 | US20110256110 Amniotic fluid cells and uses thereof |
| 10/20/2011 | US20110256109 Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof |
| 10/20/2011 | US20110256108 Methods of selection of cells for transplantation |
| 10/20/2011 | US20110256095 Tissue Matrix System |
| 10/20/2011 | US20110256092 Quinoline derivatives for modulating dna methylation |
| 10/20/2011 | US20110256090 Method for Identifying Genes Involved in Trail-Induced Apoptosis and Therapeutic Applications Thereof |
| 10/20/2011 | US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof |
| 10/20/2011 | US20110256060 Monoclonal antibody and its use for the identification of the oncofetal isoform of fibronectin (b-fn) for diagnosis or therpay |
| 10/20/2011 | US20110256058 Novel Peptides and Uses Thereof |
| 10/20/2011 | US20110256056 Monoclonal Antibodies Against HER2 Antigens, and Uses Therefor |
| 10/20/2011 | CA2796411A1 Method of obtaining a population of stromal progenitor cells |
| 10/20/2011 | CA2796317A1 New methods for isolating tr1 cells |
| 10/20/2011 | CA2796306A1 Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (alk) kinase inhibitors |
| 10/20/2011 | CA2796053A1 Methods and compositions for inhibition of treg cells |
| 10/20/2011 | CA2795643A1 Methods for generating endogenously tagged protein |
| 10/20/2011 | CA2795636A1 Use of endogenous promoters to express heterologous proteins |
| 10/20/2011 | CA2795541A1 Methods and combination |
| 10/20/2011 | CA2795078A1 Proteins that bind pi16 and uses thereof |
| 10/19/2011 | EP2378288A1 Unnatural reactive amino acid genetic code additions |
| 10/19/2011 | EP2378287A1 New method for isolating Tr1 cells |
| 10/19/2011 | EP2377939A2 Transgenic plant-based methods for plant pests using RNAi |
| 10/19/2011 | EP2377932A1 ANTI-Siglec-15 ANTIBODY |
| 10/19/2011 | EP2377930A1 A group of esterases for the enantioselective production of fine and speciality chemicals |
| 10/19/2011 | EP2377926A1 Chondrocyte-like cell, and method for producing same |
| 10/19/2011 | EP2377925A1 Hemangio-colony forming cells |
| 10/19/2011 | EP2377924A1 Hemangio-colony forming cells |
| 10/19/2011 | EP2377923A1 Hemangio-colony forming cells |
| 10/19/2011 | EP2377922A2 PDX1 expressing endoderm |
| 10/19/2011 | EP2377921A1 Method for obtaining pancreatic progenitor cell using neph3 |
| 10/19/2011 | EP2377873A1 RNAi modulation of ApoB and uses thereof |
| 10/19/2011 | EP2377404A1 A dermal micro-organ which is an explant of living tissue |
| 10/19/2011 | EP2377403A1 A genetically modified dermal micro-organ expressing factor VIII |
| 10/19/2011 | EP2377402A1 A genetically modified dermal micro-organ expressing interferon |
| 10/19/2011 | EP2377401A1 A genetically modified dermal micro-organ expressing erythropoietin |
| 10/19/2011 | EP2376641A1 Methods of modulating the sex of avians |
| 10/19/2011 | EP2376627A1 Improvements in or relating to growing cells |
| 10/19/2011 | EP2376626A2 MICROENVIRONMENT NICHE ASSAY FOR CiPS SCREENING |
| 10/19/2011 | EP2376625A1 Somatic cell-derived pluripotent cells and methods of use therefor |
| 10/19/2011 | EP2376624A2 Cell culture method |
| 10/19/2011 | EP2376125A1 Erythrocyte-based delivery system, method of preparation and uses thereof |
| 10/19/2011 | EP2376110A1 Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates |
| 10/19/2011 | EP2376087A1 Erbb-3 (her3)-selective combination therapy |
| 10/19/2011 | EP2375897A1 Methods and compositions containing mtor inhibitors for enhancing immune responses |
| 10/19/2011 | EP2375892A1 Apparatus and method for the preservation of pancreatic tissue and islet cells for transplantation |
| 10/19/2011 | EP1637590B1 Differentiated cells originating in precursor fat cells and method of acquiring the same |
| 10/19/2011 | EP1383793B1 Insulin and igf-1 receptor agonists and antagonists |
| 10/19/2011 | EP1225229B1 Gene transfer method |
| 10/19/2011 | CN1973037B Process for producing dipeptides or dipeptide derivatives |
| 10/19/2011 | CN1869235B Method for modifying plant morphology, biochemistry and physiology |
| 10/19/2011 | CN1867669B Method for producing gamma-carboxylated proteins |
| 10/19/2011 | CN1496404B Materials and methods relating to protein aggregation in neurodegenerative disease |
| 10/19/2011 | CN102224248A Lcmv-gp-vsv-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors |
| 10/19/2011 | CN102224244A Gene sensitive to normal-tension glaucoma disease, and use thereof |
| 10/19/2011 | CN102224241A Amniotic fluid cells and uses thereof |
| 10/19/2011 | CN102224240A Hematopoietic stem cell growth factor |
| 10/19/2011 | CN102224239A High titer antibody production |
| 10/19/2011 | CN102224170A Materials and methods for inhibiting cancer cell invasion related to fgfr4 |
| 10/19/2011 | CN102223886A Erbb-3 (her3)-selective combination therapy |
| 10/19/2011 | CN102220376A Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor |
| 10/19/2011 | CN102220358A High-efficiency expression vector of dicotyledonous paraquat |
| 10/19/2011 | CN102220353A Encoding sequence of Cinnamic acid-4-hydroxylase protein in sweet potato and application of same |
| 10/19/2011 | CN102220346A Antioxidation-related genes of wheat as well as coding proteins thereof and application thereof |
| 10/19/2011 | CN102220337A Hereditary medullispinal cerebellar ataxia related gene |
| 10/19/2011 | CN102220321A Molecular marker SI sv0057 closely linked with millet fertility gene |
| 10/19/2011 | CN102220298A Ferulic acid esterase FaeI as well as coding gene and application thereof |
| 10/19/2011 | CN102220297A Stress resistance associated protein TaSnRK2.3 and coding gene and use thereof |
| 10/19/2011 | CN102220289A Cellular permissivity factor for viruses, and uses thereof |
| 10/19/2011 | CN102220286A Hybridoma cell strain 2C9, anti-aflatoxin M1 monoclonal antibody produced by hybridoma cell strain 2C9 and application thereof |
| 10/19/2011 | CN102220285A Monoclonal antibody of outer membrane protein of chlamydia abortus and application thereof |
| 10/19/2011 | CN102220284A Fluorescent cell model for screening of antitumor drugs, labeling method and application thereof |
| 10/19/2011 | CN102220283A Multifunctional immune killing transgenic cell as well as preparation method and use thereof |
| 10/19/2011 | CN102220282A Method for separating leukemia stem cells from leukemia cell strain |
| 10/19/2011 | CN102220281A Co-culture system for liver cells and Kupffer cells and application thereof |
| 10/19/2011 | CN102220280A Methods of proliferating stem cells |
| 10/19/2011 | CN102220279A Coccidia cell culture model and application thereof |
| 10/19/2011 | CN102220278A Method for separating primary adult hepatocytes, and special sterile apparatus box thereof |
| 10/19/2011 | CN102220277A Method for building high-efficiency regenerating and transforming system of Oryza sativaL. subsp. japonica 11 |